Maj has a quick discussion with Cryo-cell International, Inc. (NASDAQ:CCEL) CEO David Portnoy about current events going on at the company. CCEL provides private and public cord blood banking solutions for stem cell treatments.
Specifically, David addressed questions on:
- Revenue trends
- Birth rate cause & effect on CCEL
- Pricing environment
- The company’s stem cell clinic expansion plans
- FDA approval goals
- Therapy pipeline
Enjoy these clips before watching the full video.
David Portnoy on Neurological Indications in Focus
David Portnoy on Planned Clinic Opening
Sign in to view the video the full video below. If you don’t have a premium account, consider subscribing for a free trial to access all management interviews, chats and more.
With a Subscription, you will also receive full access to our entire research service platform which includes, but is not limited to….
- Access to our entire catalog of microcap stock coverage, spanning 14 years.
- Timely alerts on new Bullish Stock Ideas and Related Updates on our entire Tier One Quality Microcap coverage universe.
- Clear opinions on our convictions, valuations and changes in our conviction.
- All ideas supported by Research Reports and in-depth Due Diligence.
- Access to our Model Portfolio of high conviction ideas.
- Portfolio Protection Research and related Red Flag Alerts.
- Participation in all Live Interviews, Fireside Chats and Q&As with microcap company executives.
- Participation in our Monthly Open Forums to discuss Geo’s microcap coverage. Hosted by Co-Founder Maj Soueidan.
- “GeoWire” monthly and weekly newsletter which includes our Weekly Wrap-Up, curated for our Premium Subscribers, highlighting our research coverage and stock idea generation that took place during the week.
- Access to all premium audio and video podcasts featuring our stock pitches and educational content.
- Stock ideas from handpicked Research Contributors who have proven to beat the market.